FDA Inspection 997577 — EMD Serono, Inc.

EMD Serono, Inc. — FEI 1220970

The FDA completed an inspection of EMD Serono, Inc. on Jan 13, 2017 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 13, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745221 CFR 312.56(c)IND safety report
748221 CFR 312.50General responsibilities of sponsors

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.